📰 Thomas Ybert News
Thomas Ybert News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thomas Ybert. Real-time updates on events, politics, business and more.
November 8, 2023
A long-term investment plan is helping the French capital to attract talent. A long-term investment plan is helping the French capital to attract talent.
December 22, 2022
As the only company to commercialize an in-house DNA manufacturing capability that utilizes the power of EDS, we are committed to developing fast, reliable, best-in-class service and support to meet research needs in the region.”
November 9, 2022
Poddevin joins DNA Script in a year of immense growth in hiring, financing, commercialization and collaborations. DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, further
October 12, 2022
L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...
October 12, 2022
The French synthetic biology company said the new distribution agreements extend its global sales and service network for the Syntax platform.
June 28, 2022
In response to strong results, the Agency has extended DNA Script's contract DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR
May 5, 2022
New Delhi [India], May 5 (ANI/NewsVoir): DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached a distribution agreement with Premas Life Sciences Pvt Ltd, India, a leading biotechnology distribution company
April 20, 2022
The University of California, Berkeley spinout hopes to stand out in the synthetic DNA race using its polymerase-nucleotide conjugation approach.
April 13, 2022
DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the launch of a new program for customers of their SYNTAX System, in which organizations receive early access to the latest advancements of their EDS technology. Dubbed the DNA Scriptors Early Access Program, its members already include the London Biofoundry and the BASE facility at the University of Queensland (UQ), Australia.
April 12, 2022
Program participants receive early access to the upcoming release of kits designed to print longer oligos and enable labeling with fluorophores, quenchers, and biotin. DNA Script, a world leader in